CANCER BUZZ

With nearly half the patients the Baheya Foundation for Early Detection and Treatment of Breast Cancer in stage 3 or 4 of the disease , delayed diagnoses are one of the biggest challenges in o ncology faced in Egypt today. This both ca u ses patients to present for treatment in more advanced stages of the disease and contribute s to a high breast cancer mortality rate in Egypt compared to other de...

Bispecific antibodies (BsAbs) have transformative potential in cancer treatment and can be successfully integrated into community oncology practices. To support this integration, ACCC is committed to providing educational initiatives and support for cancer care teams to optimize care coordination. In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor of hematology...

As a large country, economic disparities persist as a public health issue in Brazil, with 70% of the population depending on the public health system. According to Dr. Theodora Karnakis, the aging population of patients with cancer is expected to result in a 61% increase of new cancer cases between 2020 and 2040. The type of care received depends heavily on where patients are located, due to the v...

It is crucial that multidisciplinary cancer care teams stay informed about upcoming changes to Medicare Part D under the Inflation Reduction Act. To support this effort, the Association of Cancer Care Centers (ACCC) is committed to providing updated information on health care policy changes, ensuring that both providers and patients are aware of the financial benefits. In this episode, CANCER BUZZ...

Immunotherapy and targeted therapies have transformed the way patients are treated and allow more patients than ever before to survive stage IV diagnoses. Other key advancements in oncology being prioritized in Puerto Rico today include early detection and prevention efforts. However, a lack of education, access, and health insurance coverage often prevents community members from timely cancer scr...

In both high- and low-income countries, the most common struggles patients with cancer face are largely the same, including financial toxicity from treatment costs, difficulty with transportation to and from appointments, and the impact of treatment on their caregivers and families. Consistently, the greatest barrier to accessing health care in many nations is a lack of insurance coverage, often d...

UCSF Health's Seeking Care Patient Experience Team introduced web self-scheduling to improve fragmented workflows and streamline the process of seeking care from a cancer specialist. Patients now have the option to conveniently self-register and schedule appointments through 2 distinct models: direct scheduling of a new-patient appointment or use of a navigator-led intake appointment. This innovat...

CANCERBUZZ speaks with Dr. Naoto Ueno about his NOC session titled The Hawaiʻi Cancer Consortium: An Equitable Clinical Trials Initiative. Guest:  Naoto T. Ueno , MD, PhD, FACP Director Interim Program Co-Leader, Cancer Biology Program, Translational and Clinical Research University of Hawaiʻi Cancer Center Resources: ACCC 41st National Oncology Conference

CANCERBUZZ speaks with Melanie Grant about her NOC session titled Navigating Access and Equity: Providing the Answers That Matter.   Guest:  Melanie Grant , Esq. Staff Attorney Triage Cancer   Resources: ACCC 41st National Oncology Conference  

CANCERBUZZ speaks with guests at the 2024 NOC Gala event about what they are looking for at the conference.    Guests:  Una Hopkins , DNP, MSN, BSN, FNP-BC, NE-BC, FACCC, RN ACCC President-Elect Director for Research and Evidence Based Practice Montefiore Medical Center Bronx, NY   Nadine Barrett , PhD, MA, MS ACCC President Senior Associate Dean, Research Equity and Community Engagement Wake Fore...

CANCERBUZZ speaks with Terry Keys about his NOC session titled Empowering Partnerships: Enhancing Cancer Research Through Patient Advocacy.  Guest:  Terry Keys Patient Advocacy Manager Staff Senator – President's Advisory Committee University of Kentucky Markey Cancer Center Lexington, KY   Resources: ACCC 41st National Oncology Conference

CANCERBUZZ speaks with ACCC President Dr. Nadine Barrett about this year's NOC theme: Realizing Innovation. Listen to what's new in conversations and oncology education in 2024. Guest:  Nadine Barrett , PhD, MA, MS ACCC President Senior Associate Dean, Research Equity and Community Engagement Wake Forest School of Medicine Durham, North Carolina   Resources: ACCC 41st National Oncology Conference

CANCERBUZZ speaks with ACCC's Immediate Past President Dr. Olalekan Ajayi about the international panel held at NOC this year, where cancer care providers from around the world share and learn from common challenges and best practices.    Guest:  Olalekan Ajayi , PharmD, MBA Chief Operating Officer Highlands Oncology Group  Fayetteville, Arkansas   Resources: ACCC 41st National Oncology Conference

CANCERBUZZ speaks with Magbis Nunez Love about her NOC session titled Renacer: Culturally Tailored, Patient-Centered Survivorship Care Improves Access and Outcomes.   Guest:  Magbis Nunez Love , MHR Community Liaison Atrium Health Levine Cancer/Wake Forest Baptist Comprehensive Cancer Center Charlotte, NC   Resources: ACCC 41st National Oncology Conference

Discussions from the ACCC 50th AMCCBS held from February 28 to March 1, 2024, were used to develop the 2024 Trending Now in Cancer Care Part 1 and Part 2 reports. Download Part 1 for a look at trends in collaborative care delivery models, community engagement in cancer prevention, oncology workforce challenges, and the provision of comprehensive cancer care services. Download Part 2 for an examina...

Staying abreast of recent clinical practice guidelines for the management of relapsed/refractory mantle cell lymphoma can be challenging for providers who may seldom encounter it in community practice. In this episode, CANCER BUZZ speaks with Jeff Sharman, MD, medical director of hematology research, US Oncology, and director of research, Willamette Valley Cancer Institute, about the role of bioma...

Designing a health equity playbook starts with a deep understanding of the patients you serve. Successful playbooks have components that build on the patient experience, the protocols that are in place to ensure the cancer program is meeting the unique needs of all its patients, and staff education and and training on how to best serve those different patient populations. When developing a health...

The range of frontline therapy options for mantle cell lymphoma can influence subsequent treatment choices for patients with relapsed or refractory disease. Providers must determine initial treatment based on individual patient characteristics, while also factoring in future treatment options. In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP, associate professor of medicine at Medical...

Advancements in treatment combined with a multimodal approach are improving outcomes for patients with head and neck cancer. However, the unique challenges of a head and neck cancer diagnosis and its treatment side effects—such as speech and communication difficulties as well as negative effects on body image and self-esteem—can significantly impact a patient's mental health. In this episode, CANC...

Female sexual dysfunction is a well-studied adverse effect of cancer treatment. Despite its prevalence, however, it remains vastly underdiagnosed and undertreated in oncology patients, with providers inadequately addressing sexual function before, during, and after treatment. Although most patients prefer that their providers initiate conversations regarding sexual health, providers may be reticen...

Effective partnerships between dermatologists and oncologists are an essential component of care coordination for patients with advanced non-melanoma skin cancers. This interprofessional collaboration can be more challenging in the community setting, where fewer resources are available in comparison to large academic medical centers. In this podcast episode, CANCER BUZZ speaks with Emily Smith, MD...

Novel cancer therapies have emerged over the past 10-15 years with high rates of cutaneous side effects, leading to increased demand for specialists in oncodermatology. These subspecialists have expertise in managing therapeutic complications, cutaneous metastases, and proactive management of potential adverse events. In this episode, CANCER BUZZ TV speaks with guest Meghan Heberton, MD, director...

Common adverse events associated with treatment of mantle cell lymphoma include gastrointestinal, hematologic, and cardiac toxicities. Proactive management of these toxicities and collaboration between members of the cancer care team, including pharmacists, are key to optimizing patient outcomes. In this episode, CANCER BUZZ speaks with Karen Fancher, PharmD, BCOP, clinical pharmacy specialist in...

Effective communication between patients and healthcare providers is crucial to facilitate shared decision-making and meaningful dialogue that supports improved patient outcomes in diffuse large B-cell lymphoma (DLBCL) care. In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medi...

Anemia presents a significant challenge in the management of patients with low-risk myelodysplastic syndromes (MDS). Given the considerable potential for symptom burden associated with anemia in patients with MDS, health care professionals must prioritize enhancing quality of life when evaluating treatment options. In this episode, CANCER BUZZ speaks with David Sallman, MD, associate member in the...